Cytosorbents Corp (NASDAQ:CTSO)

6.07
Delayed Data
As of Jul 27
 -0.22 / -3.50%
Today’s Change
4.40
Today|||52-Week Range
15.24
-38.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$155.8M

Company Description

CytoSorbents Corp. is a development stage critical care focused company using blood purification to treat life-threatening illnesses. The technology is based upon biocompatible, porous polymer sorbent beads that are capable of extracting unwanted substances, such as drugs, dangerous chemicals, toxins, cytokines, free hemoglobin, and antibodies, from blood and other bodily fluids. The company was founded on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Contact Information

CytoSorbents Corp.
7 Deer Park Drive
Monmouth Junction New Jersey 08852
P:(732) 329-8885
Investor Relations:
17323298885777

Employees

Shareholders

Individual stakeholders34.25%
Mutual fund holders2.70%
Other institutional1.13%

Top Executives

Phillip P. ChanPresident, Chief Executive Officer & Director
Vincent CapponiChief Operating Officer
Kathleen P. BlochChief Financial Officer & Secretary
Robert Hawes BartlettChief Medical Officer
Christopher CramerVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account